Agile Therapeutics Announces Favorable Outcome of FDA Advisory Committee Meeting for its Investigational Transdermal Contraceptive Patch, Twirla® (AG200-15)

Stock Information for Agile Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.